The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Europe Edition

  • ID: 3942371
  • Report
  • Region: Europe
  • 90 pages
  • PatientView
1 of 4

FEATURED COMPANIES

  • AbbVie
  • Baxalta
  • Eisai
  • Hospira
  • Mylan
  • Sandoz
  • MORE

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 797 patient groups based in the Europe (Western and Eastern) in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the European pharma industry during 2015, as well as the performance of 45 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.

The report also offers, as case studies, survey responses from five companies, AbbVie Europe, Eisai, Janssen EMEA, Sanofi and Teva. These companies explain what they are doing on the subject of global patient centricity, and comment about their relationships with patient groups.

“The perception [of pharma] has changed in the last years, associating more to research.”
— National patient group in Spain specialising in mental health

Profiles of the 45 Companies, According To the Patient Groups in Europe Familiar with These Companies or Have Worked With Them

Each profile contains

Company Background Information

  •  Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
  •  The profiled company’s main treatment subject areas (and areas of R&D).
  •  A mission statement from the profiled company.

How the Company has Performed at Six Indicators of Corporate Reputation

  •  The profiled company’s performance at the six indicators of corporate reputation in 2015, according to the patient groups in Europe familiar with the company.
  •  The profiled company’s performance at the six indicators of corporate reputation, according to the patient groups in Europe that have worked with the company.
  •  How the profiled company performed in Europe for different therapy areas, compared with the company’s averages in Europe across all therapy areas in 2015.
  •  How the profiled company performed in Europe for different countries/regions, compared with the company’s averages in Europe in 2015.

How the Company Ranks For Corporate Reputation Compared With Other Companies

  •  The profiled company’s rankings in Europe in 2015 for the six indicators of corporate reputation, compared with 44 other companies 
  •  The profiled company’s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 44 other companies

Profile of the Patient Groups Familiar with the Company

  •  Other companies that partner with a significant number of the profiled company’s partner patient groups.
  •  The therapy areas and countries of the patient groups familiar with the profiled company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • Baxalta
  • Eisai
  • Hospira
  • Mylan
  • Sandoz
  • MORE

ABOUT THIS REPORT

WHAT DID PATIENT GROUPS IN EUROPE SAY ABOUT PHARMA IN 2015?

  • Summary of the industry-wide finding in Europe

 A FEW COMMENTS ON THE EUROPEAN CORPORATE RANKINGS
 
WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION?
 
COMMENTS FROM PATIENT GROUPS IN EUROPE, 2015
 
CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT...

  • AbbVie
  • Eisai
  • Janssen EMEA (pharmaceutical companies of Johnson & Johnson)
  • Sanofi

 METHODOLOGY OF THE PATIENT-GROUP SURVEY  
 
QUESTIONNAIRE FOR PHARMA COMPANIES 2015
 
APPENDIX 1: Data on how patient groups in Europe see the pharmaceutical industry in 2015, and in 2014
APPENDIX 2: Rankings of the 45 pharma companies for each of the 6 indicators of corporate reputation, as perceived by patient groups in Europe in 2015, compared with 2014
APPENDIX 3: Profiles of the 45 companies
APPENDIX 4: Profiles of the 797 respondent patient groups
 
LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF PATIENT GROUPS IN EUROPE
Percentage of patient groups in Europe claiming familiarity with the company Page
Percentage of patient groups in Europe claiming familiarity, and which also worked with the company
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at fair pricing
Rising stars in Europe 2015 (companies that have risen up the ranks 2015 v 2014, or lead the ranks in 2015)
If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015?
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the pharma industry in 2015?What do you think has happened to the corporate reputation of the pharma industry over the past five years?
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
(Year-on-year comparators: Europe 2015, Europe 2014, and global 2015)
Companies with the most effective patient-centred strategy (rankings of 45 companies, 2015; rankings of companies, 2014)
Companies providing the best high-quality patient information (rankings of 45 companies, 2015; rankings of companies, 2014)
Companies with the best record on patient safety (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Companies with the most-useful high-quality products (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Companies with the best record of transparency (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Companies with the best record on integrity (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Rankings of the 45 pharmaceutical companies in 2015, ALPHABETIC ORDER
Rankings of the 45 pharmaceutical companies in 2015, HIGHEST TO LOWEST

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie
  • Actavis
  • Allergan
  • Almirall
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Baxalta
  • Bayer
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Chiesi Farmaceutici
  • Eisai
  • Eli Lilly (Lilly)
  • Ferring
  • Gedeon Richter
  • Gilead Sciences
  • Grünenthal
  • GSK
  • Hospira
  • Ipsen
  • Janssen Pharmaceutical Companies of Johnson & Johnson
  • LEO Pharma
  • Lundbeck
  • Menarini
  • Merck & Co
  • Merck KGaA
  • Mylan
  • Novartis
  • Novo Nordisk
  • Octapharma
  • Otsuka
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Servier
  • Shire
  • Stada Arzneimittel
  • Takeda
  • Teva
  • UCB
  • ViiV Healthcare
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll